首页> 美国卫生研究院文献>other >Screening of a large cohort of Leber congenital amaurosis andretinitis pigmentosa patients identifies novel LCA5 mutationsand new genotype-phenotype correlations
【2h】

Screening of a large cohort of Leber congenital amaurosis andretinitis pigmentosa patients identifies novel LCA5 mutationsand new genotype-phenotype correlations

机译:大量Leber先天性黑ital病的筛查和色素性视网膜炎患者发现新的LCA5突变和新的基因型-表型的相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To investigate the prevalence of sequence variants in LCA5 in patients with Leber congenital amaurosis (LCA), early onset rod-cone dystrophy (EORD) and autosomal recessive retinitis pigmentosa (RP), to delineate the ocular phenotypes, and to provide an overview of all published LCA5 variants in an online database._Patients underwent standard ophthalmic evaluations after providing informed consent. In selected patients, optical coherence tomography (OCT) and fundus autofluorescence imaging was possible. DNA samples from 797 unrelated patients with LCA and 211 with the various types of RP were screened by Sanger sequence analysis of all LCA5 exons and intron/exon junctions. Some LCA patients were pre-screened by APEX technology or selected based on homozygosity mapping. In silico analyses were performed to assess the pathogenicity of the variants. Segregation analysis was performed where possible. Published and novel LCA5 variants were collected, amended for their correct nomenclature, and listed in a Leiden Open Variation Database (LOVD). Sequence analysis identified 18 new probands with 19 different LCA5 variants. Seventeen of the 19 LCA5variants were novel. Except for two missense variants and one splice sitevariant, all variants were protein-truncating mutations. Most patients expresseda severe phenotype, typical of LCA. However, some LCA subjects had better visionand intact inner segment/outer segment (IS/OS) junctions on OCT imaging. In twofamilies with LCA5 variants, the phenotype was more compatiblewith EORD with affected individuals displaying preserved islands of RPE. One ofthese milder families harbored a homozygous splice site mutation, a secondfamily was found to have a combination of a stop mutation and a missensemutation. This is the largest LCA5 study to date. We sequenced1008 patients (797 with LCA, 211 with arRP) and identified 18 probands withLCA5 mutations. Mutations in LCA5 are arare cause of childhood retinal dystrophy accounting for ~2% of diseasein this cohort and the majority of LCA5 mutations are likelynull. The LCA5 protein truncating mutations are predominantlyassociated with LCA. However, in two families with the milder EORD, theLCA5 gene analysis revealed a homozygous splice sitemutation in one and a stop mutation in combination with a missense mutation in asecond family, suggesting that this milder phenotype is due to residual functionof lebercilin and expanding the currently known phenotypic spectrum to includethe milder early onset RP. Some patients have remaining foveal cone structures(intact IS/OS junctions on OCT imaging) and remaining visual acuities, which maybode well for upcoming treatment trials.
机译:目的调查Leber先天性黑蒙病(LCA),早期发作的视锥圆锥型营养不良(EORD)和常染色体隐性色素性视网膜炎性色素变性(RP)患者的LCA5序列变异的流行情况,以描述眼表型,并提供所有这些的概述在在线数据库中发布了LCA5变体。_患者在获得知情同意后接受了标准的眼科评估。在选定的患者中,光学相干断层扫描(OCT)和眼底自发荧光成像是可能的。通过对所有LCA5外显子和内含子/外显子连接点进行Sanger序列分析,筛选了797例无关的LCA患者和211例不同类型RP患者的DNA样品。一些LCA患者已通过APEX技术进行了预筛查或根据纯合性作图进行选择。进行计算机分析以评估变体的致病性。在可能的情况下进行分离分析。收集已发布的和新颖的LCA5变体,对它们的正确命名进行修正,并在Leiden开放变体数据库(LOVD)中列出。序列分析确定了具有19个不同LCA5变体的18个新先证者。 19个LCA5中的17个变体是新颖的。除了两个错义变体和一个剪接位点变体,所有变体均为蛋白截短突变。大多数患者表示严重的表型,典型的LCA。但是,一些LCA受试者的视力更好OCT成像上完整的内部段/外部段(IS / OS)交界处。成两半有LCA5变体的家族,其表型更具相容性与EORD一起,受影响的个体展示了保留的RPE岛。之一这些较温和的家庭有一个纯合的剪接位点突变一家人被发现具有终止突变和错义组合突变。这是迄今为止最大的LCA5研究。我们排序1008例患者(797例LCA,211例arRP)并确定18例先证者LCA5突变。 LCA5中的突变是儿童视网膜营养不良的罕见原因约占疾病的2%在这个队列中,大多数LCA5突变很可能空值。 LCA5蛋白截短突变主要是与LCA相关联。但是,在EORD较轻的两个家庭中,LCA5基因分析显示一个纯合剪接位点一个突变和一个终止突变与一个错义突变相结合第二家族,表明这种较温和的表型是由于残余功能并扩大目前已知的表型范围早期发作的RP较轻。一些患者的剩余中央凹圆锥结构(OCT成像上完整的IS / OS交界处)和剩余视力,这可能预备即将进行的治疗试验。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号